INTRODUCTION
Small G proteins and their effectors play key roles in regulating membrane transport into and from the Golgi apparatus Gillingham and Munro, 2007; Pfeffer, 2007; Short et al., 2005) . One family of small G protein effectors that are critical for several membrane transport pathways at the TGN are golgins, large coiled-coil proteins recruited to the TGN by their $45 residue C-terminal GRIP domain (Barr, 1999; Gleeson et al., 2004; Kjer-Nielsen et al., 1999a; Munro and Nichols, 1999) . There are four human TGN golgins, namely p230/golgin-245 (p230), golgin-97, GCC185, and GCC88 (Erlich et al., 1996; Fritzler et al., 1995; Gleeson et al., 1996; Griffith et al., 1997; Kooy et al., 1992; Luke et al., 2003) . Each TGN golgin is localized to a distinct subdomain of the TGN and appears to have independent functions in membrane transport (Derby et al., 2004 Lieu et al., 2007 Lieu et al., , 2008 Lock et al., 2005; Luke et al., 2003) . Recruitment of both p230/golgin-245 (p230) and golgin-97 to the TGN is mediated by the small GTPase Arl1, which binds to the GRIP domain and specifies Golgi targeting (Gangi Setty et al., 2003; Jackson, 2003; Lu and Hong, 2003; Panic et al., 2003b) .
GCC185 is essential for retrograde transport of Shiga toxin and for Rab9-dependent transport from late endosomes to the TGN Reddy et al., 2006) . In addition, GCC185 associates with CLASP proteins that are required for microtubule nucleation at the Golgi (Efimov et al., 2007) . GCC185 is located to a TGN domain distinct from the TGN golgins p230 and golgin-97 (Derby et al., 2004) . In contrast to p230 and golgin-97, GCC88 and GCC185 bind Arl1 very poorly and appear to have different membrane-binding properties (Derby et al., 2004; Lu and Hong, 2003; Reddy et al., 2006) . In addition, whereas an invariant tyrosine of the GRIP domain is important for the interaction of p230/golgin-245 with Arl1, we and others have shown that mutation of the invariant tyrosine residue had minimal effect on Golgi localization of GCC185 Reddy et al., 2006) . Moreover, early endosome-targeted Arl1 does not relocalize GCC185 (Derby et al., 2004) . Recently, Burguete et al. (2008) proposed that both Rab6 and Arl1 co-ordinate the Golgi targeting of GCC185. Analysis of the interaction of Rab6A with polypeptide fragments of GCC185 identified a helical Rab6-binding domain N-terminal to the GRIP domain. The crystal structure of a 66 residue polypeptide of GCC185 and the GTP-bound mutant of Rab6A (Q72L) demonstrated a complex of two Rab6 molecules interacting with a dimer of the Rab-binding domain of GCC185 (Burguete et al., 2008) . Furthermore the authors demonstrated that Rab6A enhanced the ability of a 110 residue fragment of GCC185 to bind Arl1 in vitro. These findings are particularly significant as they may demonstrate a novel mechanism for the membrane recruitment of an effector protein by the co-operation of two small GTPases.
A fundamental question arising from the work of Burguete et al. (2008) is whether the interactions observed with the GCC185 fragments in vitro reflect interactions that are relevant to the localization of this TGN golgin in vivo. These authors did not assess the behavior of endogenous GCC185 but rather restricted their in vivo analyses to GCC185 constructs expressed in transfected cells. One difficulty here is that overexpression of full-length GCC185 is known to perturb the Golgi structure (Derby et al., 2004) . In addition, we and others have shown that the C-terminal region of GCC185, containing the modestly conserved GRIP domain but lacking the flanking putative Rabbinding domain, is recruited to the Golgi in transfected cells (Derby et al., 2004; Kjer-Nielsen et al., 1999a; Munro and Nichols, 1999) . Given these ambiguities we have further investigated the role of Rab6 and Arl1 in the localization of endogenous GCC185. Here we report that these small G proteins are not required for the Golgi recruitment of endogenous GCC185.
RESULTS AND DISCUSSION

GCC185 Is Localized to a TGN Region Distinct from Arl1 and Rab6
We have previously shown that there is very little colocalization of GCC185 with Arl1 on Golgi membranes, in contrast to the strong colocalization of Arl1 and golgin-97. This finding is consistent with the proposal that GCC185 is localized to the Golgi by a mechanism that is distinct from that used by golgin-97 and p230 (Derby et al., 2004) . In view of the report by Burguete et al. (2008) , here we have extended these findings to determine the subdomain relationship between endogenous GCC185 and Rab6. HeLa cells were transfected with GFP-Rab6A or GFP-Rab6A' and transfected cells stained for endogenous GCC185. There was only a low level of colocalization between either GFPRab6A (Figure 1 ) or GFP-Rab6A' (not shown) and endogenous GCC185, although both molecules were found in close physical proximity to each other in the juxtanuclear region of the cell. Furthermore, use of fixation conditions to allow membrane tubules to be visualized by immunofluorescence identified GFP-Rab6A-labeled tubules arising from the Golgi region that showed no costaining for endogenous GCC185 (not shown). These results indicate that the majority of GCC185 molecules are located to a region of the TGN distinct from Rab6.
Depletion of Rab6 and Arl1 Does Not Affect GCC185 Localization In view of the reported interactions of Rab6 and Arl1 with polypeptide fragments of GCC185 in vitro (Burguete et al., 2008) , next we directly assessed whether these Golgi-localized small GTPases are responsible for membrane recruitment of endogenous GCC185. Two isoforms of Rab6, corresponding to splice variants of the same gene, are present in HeLa cells, Rab6A and Rab6A' (Del Nery et al., 2006) . Rab6A and RabA' were either individually silenced using specific siRNA targets or simultaneously silenced using an siRNA target for both Rab6A and Rab6A' (Del Nery et al., 2006) . The outcome was identical in both cases, and therefore we show only the results from the experiments using the siRNA that targets both Rab6A and RabA'. Very little Rab6 could be detected by confocal microscopy in HeLa cells transfected with the Rab6A/A' siRNA target sequence. The images presented in Figure 2 are representative of five separate transfections. Whereas 100% of control cells had detectable Rab6 by confocal microscopy, the majority (at least 80%) of siRNA-transfected cells showed little or no Rab6 staining, using an antibody that recognizes both Rab6A splice variants. Measurement of fluorescent intensity on a cell basis revealed that the majority of cells had <5% of the level of Rab6 compared with control cells. To quantify Rab6A/6A' depletion in the cell population, siRNA-transfected cells were analyzed HeLa cells were either untreated (control) or transfected with Rab6A/Rab6A' siRNA for 72 hr, fixed in 4% paraformaldehyde, and (A) stained with rabbit anti-Rab6 antibodies followed by Alexa 488-conjugated anti-rabbit IgG and monoclonal mouse anti-GM130 antibodies followed by Alexa 568-conjugated anti-mouse IgG or (B) stained with rabbit anti-GCC185 antibodies followed by Alexa 488-conjugated anti-rabbit IgG and monoclonal mouse anti-GM130 antibodies followed by Alexa 568-conjugated anti-mouse IgG. Nuclei were stained with DAPI. In (A) and (B), bar = 10 mm. (C) HeLa cells were lysed in SDS-PAGE reducing buffer and extracts resolved on a 4%-12% NuPAGE gel. Proteins were transfered to a PVDF membrane and probed with rabbit anti-Rab6 antibodies and anti-a-tubulin antibodies using a chemiluminescence detection system. The membranes were then stripped and reprobed with anti-GCC185 antibodies.
by immunoblotting ( Figure 2B ). Based on densitometry analysis, standardized to a-tubulin staining, the 23 kDa Rab6 was depleted in the population of siRNA-transfected cells by $80%. Endogenous GCC185 was detected in these siRNA-treated cells using an affinity-purified rabbit antibody. Significantly, endogenous GCC185 remained Golgi localized in all the Rab6-depleted cells (>100 cells analyzed). Measurement of fluorescent intensity of control and Rab6 siRNA-transfected cells revealed no difference in the level of endogenous GCC185 at the Golgi (not shown).
To confirm that the ablation of Rab6A/A' in these experiments resulted in a loss of Rab6 function, we analyzed the retrograde transport of Shiga toxin fragment B (STx-B) in Rab6-depleted cells, as Rab6 is essential for the transport of this toxin from endosomes to the TGN (Mallard et al., 2002) . STx-B was bound to the surface of transfected HeLa cells at 0 C and the trafficking of surface-bound Shiga toxin followed at 37 C for 90 min. In control cells, the majority of STx-B was found in the Golgi region by 90 min, as expected, whereas in Rab6-depleted cells STx-B was predominantly located in endosomal structures, indicating a block in retrograde transport from endosomes to the Golgi ( Figure S1 available online). These data show that the silencing of Rab6 was effective. Moreover, as there was no reduction of Golgi-localized GCC185 in Rab6-depleted cells, overall these results suggest that Rab6A/A' is not involved in the membrane recruitment of this TGN golgin.
The silencing of Arl1 also had no effect on the localization of endogenous GCC185. Whereas Arl1 siRNA-transfected cells showed a loss of Golgi-localized golgin-97 and p230, as expected and confirming the absence of Arl1 (Lu and Hong, 2003) , there was no reduction in the level of endogenous GCC185 ( Figure S2 ), confirming the previous conclusion that Arl1 is not required for GCC185 localization (Derby et al., 2004) .
In view of the model proposed by Burguete et al. (2008) suggesting a dual GTPase membrane attachment of GCC185, we next determined whether the silencing of both Rab6A/6A' and Arl1 influenced GCC185 localization. In cells depleted of both small G proteins, there was no apparent reduction of GCC185 in the Golgi region (not shown). In the double knockdown experiments, 80% of the cell population was efficiently depleted of Rab6 and 80% of cells showed a loss of Golgi-localized golgin-97 and p230, indicative of Arl1 depletion. All cells examined (>100) showed normal levels of Golgi-localized GCC185, based on measurement of fluorescence intensity. These results indicate that the steady-state localization of endogenous GCC185 to Golgi membranes in HeLa cells is independent of Rab6 and Arl1.
Rab6 and Arl1 Are Not Required for Recruitment of Cytosolic GCC185 to Golgi Membranes It is formally possible that the Golgi recruitment of soluble GCC185 requires Rab6 and Arl1 and, after membrane attach- HeLa cells were either untransfected (control) or transfected with Rab6A/Rab6A' siRNA, Arl1 siRNA, or siRNAs to both Rab6A/Rab6A' and Arl1 for 72 hr and incubated with 5 mg/ml BFA at 37 C for 45 min.
Cells were fixed either immediately or after a 3.5 hr BFA washout and stained with rabbit anti-GCC185 antibodies followed by Alexa 488-conjugated antirabbit IgG and monoclonal mouse anti-GM130 antibodies followed by Alexa 568-conjugated anti-mouse IgG. Bar = 10 mm.
ment, GCC185 then is stabilized by other interactions. The experiments above were performed 72 hr after transfection with siRNA, which should be sufficient time for the recycling of endogenous full-length GCC185 between the cytosol and membranes. Nonetheless, to establish whether Rab6 and/or Arl1 are directly required for recruitment of GCC185 from the cytosol to membranes, we treated cells with brefeldin A (BFA) for 45 min to dissociate the pool of membrane-bound golgin and then washed out BFA and monitored the recruitment of cytosolic GCC185 back to Golgi membranes ( Figure 3 ). GCC185 was dissociated from the Golgi in the presence of BFA and in the absence of Rab6A/6A' and/or Arl1 was efficiently recruited to Golgi membranes after a 3.5 hr washout of the drug. In the majority (70%-80%) of the 100 cells analyzed for each sample, GCC185 was recruited back to the Golgi region after BFA washout, regardless of the absence of Rab6 or Arl1, or both Rab6/Arl1 (Figure 3) . The fact that the remaining 20%-30% of treated cells did not show GCC185 recruitment to the juxtanuclear region is likely due to the absence of a reformed Golgi after the BFA washout as these cells also did not stain for the cis-Golgi marker GM130. Thus, this experiment directly demonstrates that the binding of the soluble GCC185 from the cytosol to Golgi membranes is independent of these two small GTPases.
Golgi Targeting of the C-Terminal Domains of GCC185 Is Independent of Rab6 and Arl1
We have previously demonstrated that the C-terminal 82 residue fragment of GCC185 (GRIP domain) is Golgi localized in cells transfected with a GFP fusion construct (GFP-GCC185 GRIP ). This C-terminal 82 residue fragment does not contain the putative Rab-binding domain identified by Burguete et al. (2008) . To explore the behavior of a longer polypeptide fragment of GCC185, we constructed a GFP fusion protein comprising the C-terminal 200 residues of GCC185 (aa and including approximately 60 residues of coiled-coil sequence upstream from the GRIP domain, including the putative Rabbinding domain. GFP-GCC185 C200 was concentrated in the Golgi region and colocalized with TGN markers ( Figure 4B ). Comparison of GFP-GCC185 C200 and GFP-GCC185 GRIP at similar levels of expression showed that GCC185 C200 was predominantly Golgi localized in transfected cells whereas GCC185 GRIP was localized to the Golgi as well as detected in the cytoplasm ( Figure 4A ). We have previously reported that the inclusion of sequences flanking the GRIP domain of p230/golgin-245 enhances the efficiency of Golgi localization in transfected cells (Kjer-Nielsen et al., 1999b) and is likely to be due to the stabilization of the dimeric structure of the golgin fragments (Luke et al., 2005; Panic et al., 2003a; Wu et al., 2004) . It is possible that the more efficient Golgi localization of GCC185 C200 compared with GCC185 GRIP is also due to the stabilization of a dimeric structure. 
. Depletion of Rab6 and Arl1 Has No Effect on the Golgi Targeting of the C-Terminal Domain of GCC185
HeLa cells were transfected with either Rab6A/Rab6A' siRNA or siRNAs to both Rab6A/Rab6A' and Arl1 for 48 hr then transfected again with either (A) GFP-GCC185 GRIP or (B) GFP-GCC185 c200 . After a further 24 hr, cells were fixed and permeabilized, then stained for p230 with human anti-p230 antibodies followed by Alexa 568-conjugated anti-human IgG and for Rab6 with rabbit anti-Rab6 antibodies followed by Alexa 647-conjugated antirabbit IgG. Nuclei were stained with DAPI. Bars = 10 mm.
At high levels of expression the GCC185 C200 construct perturbed the structure of the Golgi (not shown), whereas this was not the case with the GCC185 GRIP construct that lacked coiled-coil sequences. Regardless, these data demonstrate that the C-terminal GRIP domain of GCC185, without the purported Rab-binding domain, is Golgi localized.
The intracellular location of GFP-GCC185 GRIP and GFP-GCC185 C200 was analyzed in Rab6-and Arl1-depleted cells. The absence of Rab6A/6A', Arl1, or both Rab6/Arl1 simultaneously had no effect on the localization of either GFP-GCC185 GRIP or GFP-GCC185 C200 (Figure 4) . For example, quantitative analysis showed that >90% of cells expressing lowmedium levels of GFP-GCC185 C200 were Golgi localized in the absence of Rab6. Likewise >90% of cells expressing low-medium levels of GCC185 GRIP were Golgi localized regardless of the presence or absence of either Rab6 or Arl1.
In view of the above results we also examined an identical C-terminal construct reported by Burguette et al., namely a myc-tagged C-terminal 110 residue fragment of GCC185 (myc-GCC185 C110 ), which includes the putative Rab6-binding domain. At low levels of expression myc-GCC185 C110 was concentrated in the Golgi region and colocalized with TGN markers; however, at medium to high levels of expression myc-GCC185 C110 dramatically perturbed the structure of the Golgi, in a similar fashion as the C-200 construct (data not shown). As for GFP-GCC185 C200 , the Golgi location of myc-GCC185 C110 was not affected by the absence of Rab6A/6A' or Arl1 or both simultaneously ( Figure S3) . Finally, we assessed by yeast two-hybrid assays the capacity of the three C-terminal constructs of GCC185 (C-82, C-110, and C-200) to interact with Rab6. Neither C-200, C-110, nor C-82 showed a significant interaction with either Rab6A or Rab6A' (Table S1 ). The pLEX-Rab6A/A' constructs used in this analysis interact with all known Rab6 effectors (data not shown). It should be pointed out that C-200, but not C-110, bound to Rab6B (GTP), an interaction also recently reported for a C-terminal 343 residue fragment of GCC185 (Hayes et al., 2009) . In contrast to Rab6A/A' whose expression is ubiquitous, Rab6B is encoded by a separate gene and is specifically expressed in neuronal tissues and cells (Opdam et al., 2000) . Its exact function is currently unknown. The lack of an interaction of either GCC185 C-200 or GCC185 C-110 with Rab6A/A' in the yeast twohybrid assay throws into question the relevance of the Rab6A interaction detected in in vitro assays (Burguete et al., 2008) . Recently, Munro and colleagues have mapped the Rab-binding sites of the Drosophila orthologs of the GRIP domain golgins and also did not detect Rab6 binding to the C-terminal region of the Drosophila GCC185 (Sinka et al., 2008) .
Overall, these analyses show that Rab6A/A' and Arl1 do not play a role in the localization of endogenous GCC185. Our study highlights the importance of analyzing the behavior of endogenous molecules. Mutation of the Rab-binding domain (I1588A/L1595A) in full-length GCC185 was reported to abolish Golgi localization (Burguete et al., 2008) . However, it is not clear what impact the I1588A/L1595A mutation has on the structure and stability of full-length GCC185 in transfected cells. Also the impact of expression of the full-length molecule on the structure of the Golgi does not appear to have been considered in the study by Burguete et al. (2008) , but this is a relevant issue because exogenous expression of a number of full-length golgins, including GCC185, can greatly perturb the structure of the TGN (Derby et al., 2004; Gleeson et al., 2004; Luke et al., 2003) . The interaction between GTP-bound Rab6 and the 66 residues of coiled-coil sequence of GCC185 is of reasonable affinity (Burguete et al., 2008) ; however, the data from the yeast two-hybrid interaction suggest that GCC185 and Rab6 may not interact in vivo. Hence the physiological significance of this in vitro interaction is uncertain. Recent studies from the Pfeffer and Munro laboratories have shown that the coiled-coil regions of the TGN golgins contain multiple binding sites for Rab proteins (Hayes et al., 2009; Sinka et al., 2008) . The findings by these authors raise the possibility that Rab interactions with TGN golgins play a critical role in mediating the specific functions of the TGN golgins associated with membrane transport. Notwithstanding the importance of these findings in understanding the effector functions of GCC185, the data presented in this manuscript clearly indicate that Rab6 does not contribute to the Golgi localization of GCC185. Although the membrane recruitment of GCC185 is dependent on small GTP-binding proteins, the identity of the interacting G protein(s) responsible for TGN localization remains unclear.
EXPERIMENTAL PROCEDURES Antibodies
Rabbit polyclonal antibodies to human GCC88 and GCC185 have been described (Luke et al., 2003) . Rabbit antibodies to GCC185 were affinity-purified on a column of GST-GCC185 GRIP fusion protein. Human autoantibodies to p230 and affinity-purified rabbit antibodies to p230 are as described (Kooy et al., 1992) . Rabbit antibodies to human Rab6 (C-19) were purchased from Santa Cruz Biotechnology Inc (Santa Cruz, CA, USA). Monoclonal antibodies to GM130 and human golgin-97 were from BD Biosciences (NSW, Australia). Mouse monoclonal anti-a-tubulin was obtained from GE Healthcare (Rydalmere, NSW, Australia). Secondary antibodies for immunofluorescence were goat anti-rabbit IgG-Alexa Fluor 488, goat anti-rabbit IgG-Alexa Fluor 568, goat anti-rabbit IgG-Alexa Fluor 647, goat anti-mouse IgG Alexa Fluor 488, goat anti-mouse IgG Alexa Fluor 647, and goat anti-human Alexa Fluor 568 purchased from Molecular Probes (Invitrogen, Carlsbad, CA USA). Horseradish peroxidase-conjugated sheep anti-rabbit Ig and anti-mouse Ig were from DAKO Corporation (Carpinteria, CA, USA).
Constructs
A construct containing the C-terminal 82 amino acids of GCC185 (residue 1603 to 1684) fused to GFP (GFP-GCC185 GRIP ) has been described (Luke et al., 2005) . The sequence encoding the C-terminal 200 amino acids of GCC185 (residues 1485-1684) was amplified from pBluescript-SK + -KIAA0336
(provided by Kazusa DNA Research Institute, Kisarazu, Chiba, Japan) using the primers 5 0 -CCGGAATTCCGTTTCCTCTCAACAATCT-3 0 and 5 0 -CCGGAA TTCCTATCGAAGTCCAGACCA-3 0 . The PCR product was digested with EcoRI and cloned into the EcoRI site of pEGFP-C1 (GFP-GCC185 C200 ). GFP-Rab6A and GFP-Rab6A' were generated as described (White et al., 1999) . Myctagged construct containing the C-terminal 110 amino acids of GCC185 was generated as described (Burguete et al., 2008) .
RNA Interference siRNA sequences that individually target human Rab6A and Rab6A', an siRNA sequence that targets both Rab6A and Rab6A' splice variants (Del Nery et al., 2006) , and an siRNA sequence to target Arl1 and control siRNA (Lu and Hong, 2003) have been previously described. siRNA duplexes were synthesized by Sigma Proligo (Lismore, Australia).
Yeast Two-Hybrid Assays Rab6 constructs were cloned into the polylinker sites of the pLexA vector and GCC185 domains cloned into the pGAD vector, and yeast two-hybrid assays were performed as previously described (Janoueix-Lerosey and Goud, 2000) .
Cell Culture and Transfection
HeLa cells were maintained as semi-confluent monolayers in Dulbecco's Modified Eagle's media (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin, and 0.1% (w/v) streptomycin (C-DMEM) in a humidified 10% CO 2 atmosphere at 37 C. Transient transfections of fusion protein constructs were performed using FuGENE6 transfection reagent (Roche, Basel, Switzerland). Transfected cells were cultured for 24-72 hr. Transfections with siRNA were performed using Oligofectamine (Invitrogen), according to manufacturer's instruction, for 72 hr prior to analysis.
Immunofluorescence Cells on coverslips were fixed in either 4% paraformaldehyde (PFA) for 15 min or, for anti-p230 and anti-golgin-97 antibodies, methanol (À20 C) for 5 min, free aldehyde groups quenched in 50 mM NH 4 Cl/PBS for 10 min and cells permeabilized with 0.1% Triton X-100 in PBS for 4 min. Monolayers were incubated in 5% FBS in PBS for at least 15 min to reduce nonspecific staining. Monolayers were incubated with primary antibody, diluted in 5% FBS/PBS, for 45 min, washed in PBS, then incubated with secondary conjugated antibodies for 30 min. Nuclei were stained with 4 0 ,6-Diamidino-2-phenylindole dihydrochloride (DAPI) (Sigma-Aldrich, St. Louis, MO, USA) diluted to 1 mg/ml for 5 min, washed with PBS, then rinsed briefly in water. Coverslips were then blotted dry and mounted in mowiol on a microscope slide. To preserve membrane tubules, cells were fixed with 2% PFA in complete DMEM for 15 min at room temperature, then 4% PFA in PBS for 30 min at room temperature, then they were processed as described above.
Brefeldin A Treatment and Washout
Transfected cells were treated with 5 mg/ml brefeldin A (BFA) (Calbiochem, San Diego, CA, USA) diluted in serum-free DMEM at 37 C for 45 min. Cells were either fixed immediately in 4% PFA or washed with serum-free DMEM and incubated at 37 C in complete medium for 3.5 hr to allow the cells to recover in the absence of the drug. Washed-out cells were fixed in 4% PFA and processed for immunofluorescence.
Confocal Microscopy and Image Analysis
All images were acquired using a confocal laser scanning microsope (Leica LCS SP2 confocal imaging system) using a 1003/1.4 NA HCX PL APO CS oil immersion objective. GFP and Alexa 488 were excited with the 488 nm line of an Argon laser, Alexa 568 with a 543 nm HeNe laser, Alexa 647 with a 633 nm HeNe laser, and DAPI with a 405 nm UV laser. For multicolor labeling, images were collected independently. Quantitation of fluorescence intensity was assessed with the LCS Quantify option. Images were cropped in Photoshop. Scale bars represent 10 mm.
Immunoblotting
Transfected HeLa cells were lysed in SDS-loading buffer. Extracts were resolved on SDS-PAGE 4%-12% NuPAGE gels. Proteins were transferred to PVDF membrane, then probed with rabbit anti-GCC185, rabbit anti-Rab6, or mouse anti-a-tubulin antibodies, diluted in 1% BSA/PBS for 1 hr, and washed three times, each 10 min, in 0.1% Tween20/PBS. The PVDF membrane was then incubated with horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibodies, diluted in 1% BSA/PBS for 1 hr, and washed three times in 0.1% Tween20/PBS. Bound antibodies were detected by enhanced chemiluminescence (NEN, Boston, MA USA). Membranes were stripped with 25 mM glycine-HCl, pH 2, 1% (w/v) SDS in PBS then reprobed with a primary antibody. Images were captured and analyzed using the Gel Proanalyzer program (Media Cybernetics, Bethesda, MD, USA).
Internalization Assays
For Shiga toxin internalization assays, Cy3-conjugated Shiga toxin fragment B (STx-B) (Mallard et al., 1998) was bound on ice for 45 min, and cells washed and then internalized continuously at 37 C as previously described .
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